Literature DB >> 20601366

Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.

Yuko Shima1, Koichi Nakanishi, Koichi Kamei, Hiroko Togawa, Kandai Nozu, Ryojiro Tanaka, Satoshi Sasaki, Kazumoto Iijima, Norishige Yoshikawa.   

Abstract

BACKGROUND: The prognosis of children with severe IgA nephropathy showing diffuse mesangial proliferation is poor. However, the prognosis can be improved by combination therapy (prednisolone + azathioprine or mizoribine + warfarin + dipyridamole) or prednisolone alone over a 2-year period, and disappearance of glomerular IgA deposits is often observed. Details of the incidence and clinicopathological significance of glomerular IgA disappearance remain unclear.
METHODS: To investigate this phenomenon, we retrospectively screened and analysed 124 consecutive children (age ≤ 18 years at first biopsy) with newly diagnosed severe IgA nephropathy showing diffuse mesangial proliferation, who received combination therapy or prednisolone alone for 2 years and underwent repeat biopsies.
RESULTS: Among these patients, 90 received combination therapy, and 34 received prednisolone alone. After 2 years of treatment, 27 of the patients (21.8%) showed disappearance of glomerular IgA. Logistic analysis showed that IgA disappearance was associated with less severe urinary protein excretion at the end of treatment. Kaplan-Meier analysis of the long-term course revealed a significant difference in proteinuria-free survival after the 2-year treatment period between the patients with IgA disappearance and those without (P = 0.008; log-rank test). The Cox proportional hazards model showed that disappearance of glomerular IgA after the treatment was a factor significantly associated with proteinuria-free survival in both univariate and multivariate analyses.
CONCLUSIONS: The present results suggest that disappearance of IgA after 2 years of treatment indicates milder disease severity, even in patients with diffuse mesangial proliferation, and is a prognostic factor related to proteinuria-free survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601366     DOI: 10.1093/ndt/gfq387

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Long-term results of a randomized controlled trial in childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Mari Saito; Mayumi Sako; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.

Authors:  Su-Fang Shi; Su-Xia Wang; Lei Jiang; Ji-Cheng Lv; Li-Jun Liu; Yu-Qing Chen; Sai-Nan Zhu; Gang Liu; Wan-Zhong Zou; Hong Zhang; Hai-Yan Wang
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

3.  Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.

Authors:  Akira Mima
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

4.  Long-term morbidity of IgA nephropathy in children evaluated with newly proposed remission criteria in Japan.

Authors:  Shoko Matsushita; Kenji Ishikura; Shojiro Okamoto; Yusuke Okuda; Yoshinobu Nagaoka; Ryoko Harada; Riku Hamada; Tomoyuki Sakai; Yuko Hamasaki; Hiroshi Hataya; Takashi Ando; Kentaro Ogata; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2015-03-24       Impact factor: 2.801

5.  The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.

Authors:  Heyan Wu; Zhengkun Xia; Chunlin Gao; Pei Zhang; Xiao Yang; Ren Wang; Meiqiu Wang; Yingchao Peng
Journal:  BMC Nephrol       Date:  2020-07-01       Impact factor: 2.388

6.  Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.

Authors:  Keiji Sugai; Hiroyuki Ueda; Keita Morimoto; Mai Tanaka; Daisuke Takahashi; Akio Nakashima; Junichiro Kato; Hiroshi Takahashi; Yutaka Yamaguchi; Tetsuya Kawamura; Kazushige Hanaoka; Yoichi Miyazaki; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2018-12-10       Impact factor: 2.388

7.  Kidney biopsy guidebook 2020 in Japan.

Authors:  Yoshifumi Ubara; Takehiko Kawaguchi; Tasuku Nagasawa; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2021-04       Impact factor: 2.801

8.  Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.

Authors:  Mian-Na Luo; Cui-Wei Yao; Bi-Hua Xu; Yong-Zhi Xu; Wei Jing Liu; Yong-Min Feng; Jing-Li Tao; Hua-Feng Liu
Journal:  Exp Ther Med       Date:  2013-12-31       Impact factor: 2.447

9.  Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.

Authors:  Rosanna Coppo; Stéphan Troyanov; Shubha Bellur; Daniel Cattran; H Terence Cook; John Feehally; Ian S D Roberts; Laura Morando; Roberta Camilla; Vladimir Tesar; Sigrid Lunberg; Loreto Gesualdo; Francesco Emma; Cristiana Rollino; Alessandro Amore; Manuel Praga; Sandro Feriozzi; Giuseppe Segoloni; Antonello Pani; Giovanni Cancarini; Magalena Durlik; Elisabetta Moggia; Gianna Mazzucco; Costantinos Giannakakis; Eva Honsova; B Brigitta Sundelin; Anna Maria Di Palma; Franco Ferrario; Eduardo Gutierrez; Anna Maria Asunis; Jonathan Barratt; Regina Tardanico; Agnieszka Perkowska-Ptasinska
Journal:  Kidney Int       Date:  2014-04-02       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.